{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-041558","form_type":"8-K","ticker":"ELAN","cik":"0001739104","company_name":"Elanco Animal Health Inc","filed_at":"2024-04-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.832478+00:00","generated_at":"2026-06-04T04:47:04.101506+00:00","sec_items":["1.01","5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Elanco appoints two directors, reaches cooperation agreement with Ancora","bullets":["Appointed Kathy Turner and Craig Wallace to the Board effective March 29, 2024; Board size increased from 12 to 14.","Turner and Wallace join the renamed Finance, Strategy and Oversight Committee.","Cooperation Agreement with Ancora includes standstill, voting commitments, and non-disparagement provisions.","Turner held senior roles at IDEXX and Abbott; Wallace has 30+ years at Fort Dodge, Trupanion, and Ceva."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-041558","json":"https://secwatch.observer/filing/0001104659-24-041558.json","markdown":"https://secwatch.observer/filing/0001104659-24-041558.md","text":"https://secwatch.observer/filing/0001104659-24-041558.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739104/000110465924041558/0001104659-24-041558-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739104/000110465924041558/tm245182d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T04:47:04.101506+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a494c03a26","claim":"Craig Wallace was appointed as Director at Elanco Animal Health Inc.","evidence_excerpt":"On March 29, 2024, Ms. Turner and Mr. Wallace were appointed to the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1739104/000110465924041558/0001104659-24-041558-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"c517f55410","claim":"Kathy Turner was appointed as Director at Elanco Animal Health Inc.","evidence_excerpt":"On March 29, 2024, Ms. Turner and Mr. Wallace were appointed to the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1739104/000110465924041558/0001104659-24-041558-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}